日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase III Study to Confirm Clinical Similarity of MB09, a Denosumab Biosimilar, and Prolia(®) in Postmenopausal Women with Osteoporosis (SIMBA Study)

一项 III 期研究旨在确认地诺单抗生物类似药 MB09 与 Prolia® 在绝经后骨质疏松症妇女中的临床相似性（SIMBA 研究）

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics18030291
Supronik, Jerzy; Giorgadze, Elene; Blicharski, Tomasz; Sánchez-Vidaurre, Sara; Pérez-Díaz, Luis; Paravisini, Alexandra; Millán, Susana
代谢
骨质疏松
发表日期：2026
文献求助 收藏

Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study

静脉注射司库奇尤单抗治疗活动性中轴型脊柱关节炎患者的疗效和安全性：一项随机、安慰剂对照的3期研究结果

期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.42993
Deodhar, Atul; Supronik, Jerzy; Kivitz, Alan; Valenzuela, Guillermo; Kapur, Karen; Rohrer, Susanne; Dokoupilová, Eva; Richards, Hanno B; Pavelka, Karel
关节炎
发表日期：2025
文献求助 收藏

A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis

一项随机3期研究比较了拟上市的地诺单抗生物类似药RGB-14-P与参考地诺单抗在绝经后骨质疏松症女性患者中的疗效和安全性。

期刊:Osteoporosis International
影响因子:5.4
doi:10.1007/s00198-025-07711-x
Seefried, Lothar; Ferrari, Serge; Páll, Dénes; Viapiana, Ombretta; Rosa, Jan; Supronik, Jerzy; Licheva, Rodina Nestorova; Kiefer, Joachim; Jeszenői, Norbert; Horvát-Karajz, Károly; Jókai, Enikő; Takács, István
代谢
骨质疏松
发表日期：2025
文献求助 收藏

Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12

拟上市的地诺单抗生物类似药SB16与参考地诺单抗治疗绝经后骨质疏松症：3期临床试验第12个月结果

期刊:Journal of Clinical Endocrinology & Metabolism
影响因子:5.1
doi:10.1210/clinem/dgae611
Langdahl, Bente; Chung, Yoon-Sok; Plebanski, Rafal; Czerwinski, Edward; Dokoupilova, Eva; Supronik, Jerzy; Rosa, Jan; Mydlak, Andrzej; Rowińska-Osuch, Anna; Baek, Ki-Hyun; Urboniene, Audrone; Mordaka, Robert; Ahn, Sohui; Rho, Young Hee; Ban, Jisuk; Eastell, Richard
代谢
骨质疏松
发表日期：2025
文献求助 收藏

LUMIADE 3: Therapeutic Equivalence of Denosumab Biosimilar FKS518 to Reference Product in Postmenopausal Osteoporosis

LUMIADE 3：地诺单抗生物类似药 FKS518 与参考产品在绝经后骨质疏松症中的治疗等效性

期刊:Journal of the Endocrine Society
影响因子:3.1
doi:10.1210/jendso/bvaf164
Krecipro-Nizinska, Ewa; Pluskiewicz, Wojciech; Supronik, Jerzy; Szeles, Peter; Petit-Frere, Corinne; Varone, Elsa; Ferrari, Serge; Valter, Ivo
代谢
MIA
骨质疏松
发表日期：2025
文献求助 收藏

Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis

候选生物类似药 CT-P41 与参考药物地诺单抗的疗效和安全性：一项针对绝经后骨质疏松症女性的双盲、随机、活性对照的 3 期试验

期刊:Osteoporosis International
影响因子:5.4
doi:10.1007/s00198-024-07161-x
Reginster, Jean-Yves; Czerwinski, Edward; Wilk, Krzysztof; Borowy, Przemysław; Strzelecka, Anna; Budlewski, Tomasz; Janowska-Maus, Monika; Szymanowski, Krzysztof; Kwiatek, Joanna; Postol, Svitlana; Põder, Airi; Supronik, Jerzy; Kim, SungHyun; Suh, JeeHye; Han, NooRi; Kim, NaHyun; Bae, SeoHee; Silverman, Stuart L
代谢
骨质疏松
发表日期：2024
文献求助 收藏

New insight into primary hyperparathyroidism using untargeted metabolomics

利用非靶向代谢组学对原发性甲状旁腺功能亢进症的新认识

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-024-71423-1
Marta Wielogórska-Partyka, Joanna Godzien, Beata Podgórska-Golubiewska, Julia Sieminska, Maricruz Mamani-Huanca, Karolina Mocarska, Marta Stępniewska, Jakub Supronik, Bartosz Pomichter, Angeles Lopez-Gonzalvez, Gabryela Kozłowska, Angelika Buczyńska, Anna Popławska-Kita, Agnieszka Adamska, Małgorzat
代谢
发表日期：2024
文献求助 收藏

Rituximab in the treatment of Graves' orbitopathy: latest updates and perspectives

利妥昔单抗治疗格雷夫斯眼病：最新进展和展望

期刊:Endocrine Connections
影响因子:2.8
doi:10.1530/EC-22-0303
Supronik, Jakub; Szelachowska, Małgorzata; Kretowski, Adam; Siewko, Katarzyna
发表日期：2022
文献求助 收藏

Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study

强直性脊柱炎患者接受 150 mg 司库奇尤单抗治疗（有或无负荷剂量方案）的疗效和安全性：MEASURE 4 研究的 104 周结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-018-0123-5
Kivitz, Alan J; Wagner, Ulf; Dokoupilova, Eva; Supronik, Jerzy; Martin, Ruvie; Talloczy, Zsolt; Richards, Hanno B; Porter, Brian
强直性脊柱炎
免疫/内分泌
发表日期：2018
文献求助 收藏

Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)

低剂量泼尼松时间疗法治疗类风湿性关节炎：一项随机临床试验（CAPRA-2）

期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2011-201067
Buttgereit, Frank; Mehta, Daksha; Kirwan, John; Szechinski, Jacek; Boers, Maarten; Alten, Rieke E; Supronik, Jerzy; Szombati, Istvan; Romer, Ulrike; Witte, Stephan; Saag, Kenneth G
关节炎
APR
发表日期：2013
文献求助 收藏